Metabolic Bone Disease: What's New in 2017

This online enduring material is a reproduction of the live session that was held at the 2017 AACE Annual Meeting in Austin, TX.

Target Audience

All physicians and allied health professionals interested in the study, diagnosis, and treatment of endocrine-related diseases.

Learning Objectives

  • Discuss the latest recommendations for the diagnosis and treatment of postmenopausal osteoporosis
  • Review the 2016 AACE Postmenopausal Osteoporosis Treatment Algorithm
  • Discuss controversies in the long term management of postmenopausal osteoporosis
  • Understand the cellular defects in bone from hyperglycemia
  • Define the clinical manifestations of diabetic osteopathy
  • Delineate the treatment options for diabetic bone disease
  • Apply the AACE guidelines to prevention of osteoporosis
  • Review approach to those that can benefit the most from pharmacological therapy
  • Differentiate treatment options to individualize therapy approach
  • Summarize the effectiveness and limitations of current treatments
  • Interpret the results of studies evaluating the skeletal effects of abaloparatide
  • Explain the treatment effects of inhibiting sclerostin activity
  • Review the evidence behind the potential link between vitamin D and type 2 diabetes
  • Appreciate the potential pitfalls in interpreting the available evidence
  • Review current recommendations and review ongoing studies on vitamin D and diabetes
Additional information
Faculty Disclosures71.54 KB
Available for MOC Points?: 
Practice Area: 
Parathyroid & Bone
Course summary
Available credit: 
  • 2.75 AMA
  • 2.75 Attendance
Course opens: 
Course expires: 

The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 2.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


The American Association of Clinical Endocrinologists (AACE) recognizes that you are a life-long learner who has chosen to engage in continuing medical education to identify or fill a gap in knowledge, skill or performance. As part of AACE’s duty to you as a learner, you have the right to expect that your continuing medical education experience with AACE includes:


  • Promotes improvements or quality in healthcare;
  • Is Valid, reliable and accurate;
  • Offers balanced presentations that are free of commercial bias for or against a product/service;
  • Is vetted through a process that resolves any conflicts of interest of planners, teachers or authors;
  • Is driven and based on learning needs, not commercial interests;
  • Addresses the stated objectives or purpose; and
  • Is evaluated for its effectiveness in meeting the identified educational need.


  • Supports learners’ ability to meet their individual needs;
  • Respects and attends to any special needs of the learners;
  • Respects the diversity of groups of learners; and
  • Is free of promotional, commercial and/or sales activities.


  • Relevant financial relationships planners, teachers and authors have with commercial interests related to the content of the activity; and
  • Commercial support (funding or in-kind resources) of the activity.

Date of Original Release: Friday, May 5, 2017

For questions regarding this CME activity, please contact the AACE CME Department through the 'Contact Us' webform or

Copyright 2018, AACE. All rights reserved. No part of this enduring material may be reproduced or transmitted in any other form or by any other means, electronic or mechanical, without first obtaining written permission from AACE.

Available Credit

  • 2.75 AMA
  • 2.75 Attendance

Accreditation Period

Course opens: 
Course expires: 


Please login or register to take this course.